Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions show a positive outlook on NMN's potential for health improvements, with examples like mentions of doses (600 mg being optimal) and effects on NAD levels, physical endurance, and aging markers. The tone uses supportive language like 'great' and 'evidence,' indicating enthusiasm and high interest. Additionally, references to clinical trials and expert opinions highlight a deep engagement with the research's implications, although some posts hint at ongoing debates or skepticism regarding broader impacts.
Most discussions support the positive findings about NMN's safety and benefits, emphasizing increased NAD levels, physical performance, and health markers like blood pressure and cholesterol.
Posts demonstrate high curiosity, with many referring to specific doses and potential health impacts, reflecting strong engagement with the topic.
Several discussions reference detailed studies, clinical trial results, and experts like Dr. Sinclair, indicating deep analysis and active participation.
The collective tone suggests that these findings could influence health and longevity practices, although some skepticism remains about broader implications.
Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 & 900 mg NMN groups compared to placebo at both days 30 and 60 (all p < 0.01) https://t.co/ITH2Qmmxqz
https://t.co/Z10ngiBYkF 3/3
@davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group and stayed unchanged in all NMN-treated groups at day 60." https://t.co/CCRV1yxioE
NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600 mg/day as the optimal dose. Learn more from in #LifespanNews from @Ryan0Shea - https://t.co/8bRz70EKWU #longevity #NMN https://t.co/WYysBuyXba
In humans, walking distance increases during a six-minute walking test with 300 mg, 600 mg, and 900 mg groups, compared to placebo at days 30 and 60 (all p < 0.01), though increased NAD levels in muscle aren't seen https://t.co/ITH2Qmn5g7
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/FCIFNDUa9c
This video discusses the decline of NAD in aging and how NMN supplementation can boost NAD levels, potentially supporting metabolic health, stress resistance, and longevity with proven safety and efficacy in clinical…
This clinical trial tested the effects of NMN supplements on healthy middle-aged adults over 60 days, focusing on blood NAD levels, safety, and physical performance. Results showed significant increases in NAD levels…
This video discusses the efficacy and safety of Uthever, an NMN supplement, in a randomized, double-blind study involving adults aged 40 to 65. Results indicate significant increases in NAD levels and improved insulin…
This video consolidates clinical studies on NMN supplementation in humans. It discusses the significant increase in NAD/NADH levels observed in participants, suggesting potential anti-aging effects. Additionally, it…
A recent study shows that NMN supplementation elevates NAD levels and improves walking distance in healthy middle-aged adults. The research highlights 600 mg daily as the optimal dose with significant benefits and no…
This clinical trial tested the effects of NMN supplements on healthy middle-aged adults over 60 days, focusing on blood NAD levels, safety, and physical performance. Results showed significantly increased NAD levels and…
This clinical trial examined the effects of NMN supplements on healthy middle-aged adults over 60 days, focusing on blood NAD levels, safety, and physical performance. Results showed significant NAD increases and…
This study tested the safety and effectiveness of taking Nicotinamide Mononucleotide orally in healthy individuals, showing it increased blood NAD levels without side effects over 12 weeks. It suggests NMN as a…
This video explores the growing interest in NMN and NR supplements and their potential benefits. Focused on scientific findings, it examines which supplement may be more effective for boosting NAD levels and the…
If you're in your 40s or suffer from chronic conditions, consider NAD supplements as they may promote healthier aging. This video explains the importance of NAD, its depletion's impact on health, and how boosting agents…
Dive into the groundbreaking world of NMN through the latest human clinical trials. Explore compelling findings on how NMN may influence human longevity, potentially prevent diseases, and enhance cognitive health. Join…
NAD, or nicotinamide adenine dinucleotide, is crucial for human health. This video discusses its role in over 500 enzymatic reactions and explores NAD's importance in chronic disease management and anti-aging therapies…
This clinical trial tested NMN's effects on healthy middle-aged adults over 60 days, focusing on NAD levels, safety, and physical performance. Results showed significant NAD increases and improved walking test scores…
Yi L, Maier AB, et al. “The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-con - https://t.co/etVURlQ7QT
Yaşlandıkça Azalan Bir Madde, Nasıl Gençleşirim?, Aktüel Sağlık, Bir Dak... https://t.co/4x4lMP6TbK @YouTube aracılığıyla
Yaşlandıkça Azalan Bir Madde, Nasıl Gençleşirim?, Aktüel Sağlık, Bir Dak... https://t.co/3JqlIaANtS via @YouTube
Yaşlandıkça Azalan Bir Madde, Nasıl Gençleşirim?, Aktüel Sağlık, Bir Dak... https://t.co/ZQ3LcQEkZx @YouTube aracılığıyla
Yürümek en iyi ilaçtır. Hipokrat NAD, NMN Sağlıklı yaşamın 4 koşulu: Düzenli, dengeli beslenme. Yakabilaceğin kadar ye. Uyku düzenine dikkat et. Egzersiz yap. https://t.co/ygRo8RrUDQ
https://t.co/Cc9Zwjbkss
RT @BortaRuslan: Cтало известно как клетки запасают вещество, тормозящее старение и как э... https://t.co/uTFHjAxn2o через @YouTube
Cтало известно как клетки запасают вещество, тормозящее старение и как э... https://t.co/uTFHjAxn2o через @YouTube
@Regenity888 @davidasinclair https://t.co/pUqy0aT58Q There is some research on humans and dosing.
https://t.co/bGOcOlKsps
RT @gglinskii: The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized,…
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/6QC9oTXrmX
RT @davidasinclair: In humans, walking distance increases during a six-minute walking test with 300 mg, 600 mg, and 900 mg groups, compared…
RT @davidasinclair: In humans, walking distance increases during a six-minute walking test with 300 mg, 600 mg, and 900 mg groups, compared…
In humans, walking distance increases during a six-minute walking test with 300 mg, 600 mg, and 900 mg groups, compared to placebo at days 30 and 60 (all p < 0.01), though increased NAD levels in muscle aren't seen https://t.co/ITH2Qmn5g7
RT @MarcosArrut: @SupraKerogaz @steve_papito Here, educate yourself: https://t.co/ax93vWy5IM
@SupraKerogaz @steve_papito Here, educate yourself: https://t.co/ax93vWy5IM
NMNって2021年頃に調べた時はまだなんか怪しいサプリの一つだった印象だけど、2022年にRCTで安全性と有効性が確認できてたんだ、気になってきたな https://t.co/UOat3TPtmU
https://t.co/CNClMnhnWk
@HankC88475 couple studies https://t.co/KtdQdxemri https://t.co/ozFZkEapFX
RT @ChsCamsKsu: ننتظركم بحماس غدا الأربعاء ١ مايو في سيمنار القسم ✨ The efficacy and safety of β‐nicotinamide mononucleotide (NMN) supplem…
RT @ChsCamsKsu: ننتظركم بحماس غدا الأربعاء ١ مايو في سيمنار القسم ✨ The efficacy and safety of β‐nicotinamide mononucleotide (NMN) supplem…
RT @ChsCamsKsu: ننتظركم بحماس غدا الأربعاء ١ مايو في سيمنار القسم ✨ The efficacy and safety of β‐nicotinamide mononucleotide (NMN) supplem…
RT @ChsCamsKsu: ننتظركم بحماس غدا الأربعاء ١ مايو في سيمنار القسم ✨ The efficacy and safety of β‐nicotinamide mononucleotide (NMN) supplem…
RT @ChsCamsKsu: ننتظركم بحماس غدا الأربعاء ١ مايو في سيمنار القسم ✨ The efficacy and safety of β‐nicotinamide mononucleotide (NMN) supplem…
ننتظركم بحماس غدا الأربعاء ١ مايو في سيمنار القسم ✨ The efficacy and safety of β‐nicotinamide mononucleotide (NMN) supplementation in healthy middle‐aged adults By:Aldanah Alshathri https://t.co/Ps3FSlaCfh Looking forward to seeing you all!
7. NMN: A 2022 NMN clinical trial with 80 participants ranging between the ages of 40 and 65, confirmed that 600 mg/day of NMN effectively raises NAD levels in the blood. https://t.co/F0DloHPAZr
RT @agingdoc1: The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized,…
@CarDen1974 @AndreasLeeraar @DaanDeWit @john_bumblebee Bekend met deze studie? https://t.co/BJA5hMF3ql
There have been 16 Human NMN Trials, why do some skeptics only cover 12? https://t.co/4NEbdKvqPo #livelonger #livelong #healthylifestyle #healthyliving #healthylife #healthy #biohacking #wellbeing #guthealth #holistic #detox #healthyfood #HealthyHabits #selfcare https://t.co/63HwDsiL0O
I take NMN. https://t.co/zOabBF2OiJ
https://t.co/hnw5bxUXzi ¿Por qué querría la industria farmacéutica asegurarse derechos exclusivos sobre este producto? ¿Por qué un suplemento dietético es peligroso para la industria farmacéutica?
RT @JamesPreuss: @tofar1 Sparked my curiosity... NAD+ is so important for the body, particularly as we age. Apparently, NMN occurs highest…
@tofar1 Sparked my curiosity... NAD+ is so important for the body, particularly as we age. Apparently, NMN occurs highest in Avocado, Edamame, cucumber, broccoli, tomato, cabbage etc. Also may not get enough as we age so a supplement is great. https://t.co/ovMpJrbDMy
@JuhoTala @Do_Not_Age Hi, this may help, it will at least give you Info on ALL the human trials (links to all trials too). 1 key thing to remember, NMN is JUST an NAD Booster, its ONLY job is to boost NAD, anything else is a bonus. https://t.co/A5FUXDPk68
@lemire Last time I was into the research, that's where all the excitement was, specifically from guys like Dr. Sinclair. They proved it can boost NAD+ now effectively, but whether that "anti ages" downstream is still in trial. https://t.co/pHN8BA58BA
They don’t want longevity and healthy, they want people sick. https://t.co/u6VEHmX7Tt https://t.co/kB4Puc3Doy
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @agingdoc1: The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized,…
RT @agingdoc1: The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized,…
RT @agingdoc1: The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized,…
RT @agingdoc1: The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized,…
RT @agingdoc1: The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized,…
RT @agingdoc1: The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized,…
RT @agingdoc1: The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized,…
RT @agingdoc1: The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized,…
RT @agingdoc1: The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized,…
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/FCIFNDUa9c
RT @Ryan0Shea: One reason to watch the new episode of #LifespanNews, even if you don't care about NMN & whether or not if can boost your he…
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/z9MzQ4HjJH
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/Gf8I2O0BVT
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/tRo3ufgf7b
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/QDLl8tCXb4
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/F0j6lwKMeg
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/Dway5aqcHn
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/U9SQyMmKvw
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/niSOwzk34a
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/h7oho01yM1
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
NMN supplementation in healthy, middle aged adults showed blood pressure and cholesterol improvements as well as performance improvements measured using the 6-minute walk test⬇️ #PSUClinExPhy @invinceible24 https://t.co/1WsJ6Z8y7L
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
@BradStanfieldMD Thoughts on this summary of human clinical NMN trials? https://t.co/wQRZvrAWkt
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/IDlYppkJ8P
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @ARebel562: @davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group…
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
@davidasinclair Concurrent Singapore Feb 2023 B-NMN: "The blood biological age increased significantly in the placebo group and stayed unchanged in all NMN-treated groups at day 60." https://t.co/CCRV1yxioE
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
RT @davidasinclair: Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 &…
Walking distance increase during the 6-minute walking test was statistically significantly higher in the 300 mg, 600 & 900 mg NMN groups compared to placebo at both days 30 and 60 (all p < 0.01) https://t.co/ITH2Qmmxqz
#NMN human trials so far. No adverse effects. #NAD levels increased. Positive effects on physical strength, cardiovascular health, blood pressure and metabolic syndrome (weight loss, blood sugar … ). https://t.co/fczuxxDfHw
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/mxUd02w1Qo
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/txahKoVYPK
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/M84BTP0Gu3
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/qIv8LJHf8b
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/jumAjp8ggR
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/qFBBjXNhc3
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/n9KM32RvjD
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/aGvDyfH0Bf
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/uEXBkLRzHs
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/UlTFEBWumG
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/lkz69m6qXu
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/jRTUxdtkBO
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/oLBUW7mfzG
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/HV9gkYtP0R
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/yXMN94bLNL
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/SI2NetVhYA
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/MLZfhFGpq9
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/4QuUsoo5Dm
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/aVh4yxSfxT
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/1ViScs2ymR
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/qDVm9fQm3b
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/1X71HuOM2y
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/3O2qzmKycf
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/gqY501TjAC
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/ygKmCbeDOn
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/rB4N2S6A9W
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/dX2WpS9eo4
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/ijSZFM4iXZ
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/dYe6X3QeqB
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/Jbdn6zHAGW
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/bx8XCnrxMx
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/gdTlWdM0UD
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/oyjCcnoobX
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/N9rn42fPYS
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/DBATe8DRVb
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/tgV17D36eG
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/UOPg0tG9Ok
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/lqlh6LEWJg
米Abinopharm社と中国ABA Chemicals社が資金提供した、40-65歳のインド健常成人80名を用いたランダム化比較試験で、NMN 300、600、900mgを60日間摂取させたところ、600 or 900mg摂取群でNAD+レベルの上昇が大きく、6分間歩行距離の向上が見られたことを報告しています。 https://t.co/mAs3xKrqhg
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/dkBvsELs1Z
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/Yqsy0Yziti
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/UEirHkmiER
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/bRMo9kRADL
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/R3QXYQvJLQ
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/FyHaM3Jw2w
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/UtN1zpVuWF
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/JtnGcOFEzP
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/TFQf8pWgMU
RT @davidasinclair: https://t.co/Z10ngiBYkF 3/3
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/4zXQawr0Hf
@BradStanfieldMD @RoryPaltridge @davidasinclair @BrighamWomens @harvardmed and https://t.co/fg51cIkrPi
RT @davidasinclair: https://t.co/Z10ngiBYkF 3/3
RT @davidasinclair: https://t.co/Z10ngiBYkF 3/3
RT @davidasinclair: https://t.co/Z10ngiBYkF 3/3
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/6WC2V6Qgfy
https://t.co/scMZXawJwJ
RT @davidasinclair: https://t.co/Z10ngiBYkF 3/3
RT @davidasinclair: https://t.co/Z10ngiBYkF 3/3
RT @davidasinclair: https://t.co/Z10ngiBYkF 3/3
RT @davidasinclair: https://t.co/Z10ngiBYkF 3/3
RT @davidasinclair: https://t.co/Z10ngiBYkF 3/3
RT @davidasinclair: https://t.co/Z10ngiBYkF 3/3
https://t.co/Z10ngiBYkF 3/3
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/uV0qzGo8xW
RT @bengreenfield: Latest study shows that supplementing with NMN boosts NAD levels and increases physical performance: https://t.co/TeFBJb…
RT @bengreenfield: Latest study shows that supplementing with NMN boosts NAD levels and increases physical performance: https://t.co/TeFBJb…
Latest study shows that supplementing with NMN boosts NAD levels and increases physical performance: https://t.co/TeFBJb6IhL https://t.co/tjimrKGoWA
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/a9FnImpVEf
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/ujSRde8uVy
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/xufhn7DbAq
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/qOzEu7d0f3
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/P5vrzOzTjM
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/NHQuIZFb6m
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/AnRMhePbmf
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/rYWQqgmJDe
RT @drmikehart: A randomized controlled trial has concluded that supplementing with NMN slows biological aging and improves exercise perfor…
"Blood NAD concentrations were highest in the groups taking 600 mg and 900 mg NMN. No safety issues, based on monitoring adverse events (AEs), laboratory and clinical measures, were found, and NMN supplementation was well tolerated." #NMN #fivescorelabs https://t.co/77vuWk5pkK
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/NfkrPoBHa6
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/VOcbkDkKhV
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/D7yI3C4wYD
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/zMQ65zZl1s
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/d7E8faMRO8
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/AGRqZVplLI
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/NtRYYE3Okl
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/y8iAeUwp5V
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/Z0Kqe4Q7Uy
https://t.co/LGF3zEzkTj
RT @hernangraffe: https://t.co/LGF3zEzkTj
https://t.co/LGF3zEzkTj
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/SQWwMfIxhP
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/rtQL9t3jNB
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/VqMak6yYHL
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @hernangraffe: https://t.co/LGF3zEyN3L
https://t.co/LGF3zEyN3L
https://t.co/LGF3zEyN3L
https://t.co/CEnXmPSzYF https://t.co/TqkVU8Pc7d
https://t.co/q60W03PNjf
RT @Ryan0Shea: One reason to watch the new episode of #LifespanNews, even if you don't care about NMN & whether or not if can boost your he…
RT @Ryan0Shea: One reason to watch the new episode of #LifespanNews, even if you don't care about NMN & whether or not if can boost your he…
RT @Ryan0Shea: One reason to watch the new episode of #LifespanNews, even if you don't care about NMN & whether or not if can boost your he…
RT @Ryan0Shea: One reason to watch the new episode of #LifespanNews, even if you don't care about NMN & whether or not if can boost your he…
RT @Ryan0Shea: One reason to watch the new episode of #LifespanNews, even if you don't care about NMN & whether or not if can boost your he…
RT @Ryan0Shea: One reason to watch the new episode of #LifespanNews, even if you don't care about NMN & whether or not if can boost your he…
RT @Ryan0Shea: One reason to watch the new episode of #LifespanNews, even if you don't care about NMN & whether or not if can boost your he…
RT @Ryan0Shea: One reason to watch the new episode of #LifespanNews, even if you don't care about NMN & whether or not if can boost your he…
RT @Ryan0Shea: One reason to watch the new episode of #LifespanNews, even if you don't care about NMN & whether or not if can boost your he…
One reason to watch the new episode of #LifespanNews, even if you don't care about NMN & whether or not if can boost your health & extend your life, is because you can go frame by frame & make me make weird faces like this one. - https://t.co/zJ1ki93ajP #Longevity #NMN #YouTube https://t.co/dx738Dpx22
RT @YujiMarutani: NMN Optimal Dose & Health Benefits Revealed in New Study! https://t.co/m9DTO92v6j via @YouTube
NMN Optimal Dose & Health Benefits Revealed in New Study! https://t.co/DapMTOzLdR via @YouTube
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
NMN Optimal Dose & Health Benefits Revealed in New Study! https://t.co/m9DTO92v6j via @YouTube
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
RT @LifespanIO: NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600…
NEW: Published study shows health benefits of NMN supplementation (including an increase in NAD levels), and landed on 600 mg/day as the optimal dose. Learn more from in #LifespanNews from @Ryan0Shea - https://t.co/8bRz70EKWU #longevity #NMN https://t.co/WYysBuyXba
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/Ge6ypQS5qe
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial https://t.co/Ge6ypQS5qe
米国Abinopharm社を始めとする国際的な研究チームは、中年の健常成人80名を用いた多施設ランダム化比較試験で、NMN 300、600、又は900mgを60日間摂取させたところ、900mgでも重篤な有害事象はなく、用量依存的な身体パフォーマンス向上が見られたことを報告しています。 https://t.co/mAs3xKqSrI
RT @AndreaBMaier: Adding #evidence to Longevity Medicine: b-nicotinamide mononucleotide (#NMN) is improving physical function and quality o…
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @LongevityTao: NMN human clinical trial. The key take away that out of the 300, 600 & 900mg doses tested, the 600mg dose was probably be…
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
@BradStanfieldMD @davidasinclair He shared this link addressing the safety of NMN: https://t.co/EKX8zwrvyP
A very needed study on NMN efficacy and safety in healthy middle-aged adults. #nmn #supplements #Longevity #aging #study #results https://t.co/xNfsQBdxue
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @litguru23: Nicotinamide "supplementation had a positive impact on the physical endurance and general health conditions of healthy adult…
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
NMN supplementation increases blood NAD concentrations & is safe & well tolerated with oral dosing up to 900 mg NMN daily. Clinical efficacy expressed by blood NAD concentration & physical performance reaches highest at a dose of 600 mg daily oral intake. https://t.co/KD8jwjsmjU
@BradStanfieldMD
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
RT @davidasinclair: A recent paper on the safety and efficacy of NMN worth a read. Will summarize later https://t.co/ITH2Qmmxqz
BH